MAP Pharma(美国)

MAP Pharmaceuticals

美国MAPPharmaceuticalswww.mappharma.com美国MAP制药使用专有的吸入技术，以提高治疗效果和成熟的商业吸引力，同时尽量减少药物通过其已知的安全性，有效性和商业化的历史资本化的风险。LEVADEX™治疗成人急性偏头痛MAPPharmaceuticalsusesproprietaryinhalationtechnologiestoenhancethether apeuticbenefitsandcommercialattractivenessofprovendrugswhileminimizingriskbycapitalizingontheirknownsafety,efficacyandcommercializationhistory.TheclinicaldevelopmentprogramsatMAPPharmaceuticalsincludeproprietaryproductcandidatesthataddresslargemarketopportunities.ThemostadvancedproductcandidateisLEVADEX™orallyinhaledmigrainetherapy.Ourtechnologiesenableustodevelopproprietarydrugcandidatesfordeliveryviatherespiratorytracttomoreeffectivelytreatbothlocalrespiratoryandsystemicallytreatablediseases.Wecreateinhalabledrugparticleswiththespecificphysicalandchemicalcharacteristicstofacilitateefficientpulmonarydelivery.Webelievethiswillresultinm